CHYLOTREZ
LIVE

Serial Number

79254451

Owner

NOVARTIS AG

Filing Date

Jan 23, 2019

Add to watchlist:

No watchlists yet
View on USPTO

CHYLOTREZ Trademark

Serial Number: 79254451 • Registration: 5809695

CHYLOTREZ is a trademark filed by NOVARTIS AG on January 23, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,171 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

January 23, 2019

Registration Date

July 23, 2019

Published for Opposition

May 7, 2019

Cancellation Date

September 22, 2022

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Apr 11, 2023 DENC
DEATH OF INTERNATIONAL REGISTRATION
Apr 11, 2023 DETH
NOTIFICATION PROCESSED BY IB
Sep 27, 2019 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Sep 9, 2019 FICS
FINAL DISPOSITION PROCESSED
Sep 9, 2019 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Aug 22, 2019 GPAR
REGISTERED-PRINCIPAL REGISTER
Jul 23, 2019 R.PR
PUBLISHED FOR OPPOSITION
May 7, 2019 PUBO
NOTICE OF PUBLICATION
Apr 17, 2019 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 27, 2019 CNSA
ASSIGNED TO EXAMINER
Mar 26, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 22, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 18, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Mar 15, 2019 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Mar 14, 2019 SDRC